Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Population Good signals in people with large acute MIs at risk of developing heart failure Aug 30, 2022
Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yet Approach beats coronary access through the thigh Aug 29, 2022
Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EF SGLT2 inhibitor shines in landmark DELIVER trial Aug 27, 2022
ADVOR Backs Add-On Acetazolamide for Cutting Congestion in Decompensated HF Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says Aug 27, 2022
Mass Cardiovascular Testing May Add Years for Some Men Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
No Detrimental Impact on Cognition With Entresto for Heart Failure Cost may be reason for underutilization, rather than concerns about cognition, expert noted Aug 26, 2022
No Worsening Cardiac Dysfunction in Long COVID Other harms likely contribute to dyspnea, HF after COVID-19 hospitalization Aug 05, 2022
Heart Disease Will Surge Over the Coming Decades Worsening racial disparities are also projected Aug 01, 2022
Fluid Therapy Showdown in Cardiac Surgery Disfavors Albumin Major adverse events not reduced, and some complications increased Jul 19, 2022
Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
Which Advanced HF Patients Are Entresto-Intolerant in the Real World? 1 in 6 dropped out from the LIFE trial because of side effects Jun 27, 2022
Heart Failure Drugs Can Be Unaffordable on Medicare, Study Finds Older adults are subject to cost-sharing and other medication coverage restrictions Jun 21, 2022
TAVR Pacemaker Rate Dips to Single Digits Nationwide, but Outlier Hospitals Remain Do worst-performing sites need more education about best practices? Jun 12, 2022
Fate of Transcatheter Tricuspid Devices: Will it Be Repair or Replacement? Many unanswered questions remain regarding devices for tricuspid regurgitation Jun 11, 2022
TAVR Devices Keep Changing -- Is This Really Helping Patients? Clinical outcomes are headed in the right direction, but better research is needed Jun 10, 2022
Good News for Heart Failure Patients Getting COVID Booster Shots Group saw lower risks for hospitalization, ICU admission, death versus the unvaccinated Jun 09, 2022
TAVR for Aortic Regurgitation Off to a Good Start in the Real World Yet some growing pains remain for the Jenavalve Trilogy May 21, 2022
No-Implant Shunt Eases HF Symptoms in Early Data Quality of life consistently improved across first-in-man studies May 20, 2022
TAVR Stays Its Course as 10-Year Durability Data Trickle In Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bay Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
Systemic Corticosteroids in Acute HF: Worth Another Look? Some see a potential treatment for patients with more inflammation Apr 08, 2022
Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HF Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
EHR Pop-Ups Spur Better GDMT Implementation in Heart Failure Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Events Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classes Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor? EMPEROR-Preserved trial weighs in Mar 21, 2022
ARB-Cancer Link May Come Down to Cumulative Exposure Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
Salt in Fizzy Tablets Linked to Heart, Death Risk Warning signals seen for fast-acting acetaminophen and other drugs Feb 24, 2022
A Simple Way to Tell When Asymptomatic Aortic Stenosis Isn't So Benign Could regular NT-proBNP testing be of value to patients with non-severe AS? Feb 16, 2022
ACIP Embraces Spikevax Amid Serious Talk of Changing mRNA Dosing Interval Would longer time between doses do the trick to reduce myocarditis risk? Feb 04, 2022
Death During Sex: Not Just an Old Man Thing But sudden cardiac death remains rare even for sexually active people with heart conditions Jan 12, 2022
Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
Peak VO2 Improved After Beta-Blocker Withdrawal in Some HFpEF Patients Beta-blockers may not benefit HFpEF patients with chronotropic incompetence Nov 15, 2021
Delaying Surgery Hurts Patients With Silent Aortic Stenosis Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
More Good News for Empagliflozin in Patients With Heart Failure Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
Longstanding Vascular Closure Technique Triumphs Over Collagen Plug Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE Nov 06, 2021
TAVR Operators Divided on Need for Bicuspid RCT Odds of a study coming to fruition are low Nov 05, 2021
Too Many TAVR Centers Are Clustered Around Well-to-Do Communities More centers not the answer to geographic, socioeconomic disparities in access? Oct 22, 2021
Study: Kids Exposed to Harmful Plastics During Heart Surgery Are tubing and blood bags sources of trouble? Oct 09, 2021
Post-TAVR Pacemakers Not All Doom and Gloom A bit of reassurance from Swedish cohort study Oct 04, 2021
